NCT02077881 2026-04-03
Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer
Lumos Pharma
Phase 1/2 Completed
Lumos Pharma
Asan Medical Center
Centre Oscar Lambret
Centre Oscar Lambret
Ankara University
Incheon St.Mary's Hospital